Inventor · disambiguated record
Christoph Ullmer
Also filed as: ULLMER CHRISTOPH
15 granted patents·5 pending applications·117 citations·filing 2002–2025
92Inventor score
Top patents by PatentIndex Score
20 records- 0194US10633384B2Diazaspirocycloalkane and azaspirocycloalkaneHOFFMANN LA ROCHE·Filed 2016·Granted Apr 28, 2020·12 cites·12 claims
- 0293US10889588B2Bicyclic compounds as dual ATX/CA inhibitorsHOFFMANN LA ROCHE·Filed 2020·Granted Jan 12, 2021·3 cites·23 claims
- 0393US10647719B2Bicyclic compounds as dual ATX/CA inhibitorsHOFFMANN LA ROCHE·Filed 2018·Granted May 12, 2020·10 cites·36 claims
- 0490US10738053B2Bicyclic compounds as dual ATX/CA inhibitorsHOFFMANN LA ROCHE·Filed 2018·Granted Aug 11, 2020·5 cites·23 claims
- 0590US8309734B2Substituted pyridines as GPBAR1 agonistsBISSANTZ CATERINA·Filed 2009·Granted Nov 13, 2012·21 cites·3 claims
- 0689US9321727B2Pyridine derivatives as agonists of the CB2 receptorBISSANTZ CATERINA·Filed 2012·Granted Apr 26, 2016·19 cites·4 claims
- 0788US7060711B2Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonistBIOFRONTERA BIOSCIENCE GMBH·Filed 2002·Granted Jun 13, 2006·24 cites·10 claims
- 0885US8729091B24-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compoundsHOFFMANN LA ROCHE·Filed 2013·Granted May 20, 2014·8 cites·12 claims
- 0982US7691863B2Pyrazine-2-carboxamide derivatives as CB2 receptor modulatorsHOFFMANN LA ROCHE·Filed 2007·Granted Apr 6, 2010·11 cites·22 claims
- 1078US8987307B23-amino-pyridines as GPBAR1 agonistsBISSANTZ CATERINA·Filed 2012·Granted Mar 24, 2015·4 cites·49 claims
- 1167US11732036B2Antibody that binds to VEGF-A and ANG2 and methods of useHOFFMANN LA ROCHE·Filed 2021·Granted Aug 22, 2023·0 cites·9 claims
- 1262US2020207769A1Diazaspirocycloalkane and azaspirocycloalkaneHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1359US2020223854A1Bicyclic compounds as dual atx/ca inhibitorsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1456US7511064B2Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonistBIOFRONTERA BIOSCIENCE GMBH·Filed 2006·Granted Mar 31, 2009·0 cites·21 claims
- 1552US8354102B2Antibodies directed to mGluR7HOFFMANN LA ROCHE·Filed 2008·Granted Jan 15, 2013·0 cites·4 claims
- 1643US2025195528A1Dose regimen of vicasinabinHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 1742US10385022B23-amino-pyridines as GPBAR1 agonistsHOFFMANN LA ROCHE·Filed 2015·Granted Aug 20, 2019·0 cites·15 claims
- 1842US2016137606A1Novel pyridine derivativesHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 1941US10227308B2Radiolabeled cannabinoid receptor 2 ligandHOFFMANN LA ROCHE·Filed 2017·Granted Mar 12, 2019·0 cites·8 claims
- 2037US2003022920A11-Methyl-4- (3-ethoxy-9H-thioxanthene-9-ylidene) -piperidine and its use as 5-HT2B/H1 receptor antagonistFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christoph Ullmer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →